Vivani Medical, Inc. (VANI)
USD 0.99
(-0.01%)
USD 0.99
(-0.01%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 42 Thousand USD | 100.1% |
| 2022 | -44.12 Million USD | -11954.92% |
| 2021 | -366 Thousand USD | -194.82% |
| 2020 | 386 Thousand USD | 104.42% |
| 2019 | -8.72 Million USD | -95.15% |
| 2018 | -4.47 Million USD | 42.96% |
| 2017 | -7.83 Million USD | 27.92% |
| 2016 | -10.87 Million USD | 31.86% |
| 2015 | -15.96 Million USD | -2476.64% |
| 2014 | -619.41 Thousand USD | -103.23% |
| 2013 | 19.14 Million USD | 134.05% |
| 2012 | 8.18 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -9.27 Million USD | -22180.95% |
| 2024 Q2 | -4.88 Million USD | 47.35% |
| 2023 Q1 | -36.81 Million USD | 16.57% |
| 2023 Q3 | -3.76 Million USD | 67.25% |
| 2023 Q2 | -11.49 Million USD | 68.76% |
| 2023 Q4 | 42 Thousand USD | 101.12% |
| 2023 FY | 42 Thousand USD | 100.1% |
| 2022 Q2 | -2.01 Million USD | 62.26% |
| 2022 Q4 | -44.12 Million USD | 12.46% |
| 2022 FY | -44.12 Million USD | -11954.92% |
| 2022 Q1 | -5.35 Million USD | -1361.75% |
| 2022 Q3 | -50.39 Million USD | -2396.24% |
| 2021 Q4 | -366 Thousand USD | 99.49% |
| 2021 Q3 | -71.74 Million USD | 2.41% |
| 2021 Q2 | -73.52 Million USD | -202.61% |
| 2021 FY | -366 Thousand USD | -194.82% |
| 2021 Q1 | -24.29 Million USD | -2386.8% |
| 2020 Q3 | -2.43 Million USD | 30.47% |
| 2020 FY | 386 Thousand USD | 104.42% |
| 2020 Q1 | -2.23 Million USD | 74.41% |
| 2020 Q4 | -977 Thousand USD | 59.91% |
| 2020 Q2 | -3.5 Million USD | -56.96% |
| 2019 Q3 | -15.8 Million USD | 29.61% |
| 2019 FY | -8.72 Million USD | -95.15% |
| 2019 Q4 | -8.72 Million USD | 44.8% |
| 2019 Q2 | -22.45 Million USD | 22.26% |
| 2019 Q1 | -28.88 Million USD | -546.07% |
| 2018 Q4 | -4.47 Million USD | 10.08% |
| 2018 FY | -4.47 Million USD | 42.96% |
| 2018 Q2 | -7.47 Million USD | -49.1% |
| 2018 Q1 | -5.01 Million USD | -730.13% |
| 2018 Q3 | -4.97 Million USD | 33.49% |
| 2017 Q2 | -763 Thousand USD | -186.84% |
| 2017 Q3 | -639 Thousand USD | 16.25% |
| 2017 Q4 | -604 Thousand USD | 5.48% |
| 2017 FY | -7.83 Million USD | 27.92% |
| 2017 Q1 | -266 Thousand USD | 50.65% |
| 2016 FY | -10.87 Million USD | 31.86% |
| 2016 Q4 | -539 Thousand USD | -94.58% |
| 2016 Q3 | -277 Thousand USD | -50.54% |
| 2016 Q2 | -184 Thousand USD | 59.91% |
| 2016 Q1 | -459 Thousand USD | -92.05% |
| 2015 Q4 | -239 Thousand USD | 11.04% |
| 2015 Q2 | -407.43 Thousand USD | 37.53% |
| 2015 Q1 | -652.25 Thousand USD | -5.3% |
| 2015 Q3 | -268.65 Thousand USD | 34.06% |
| 2015 FY | -15.96 Million USD | -2476.64% |
| 2014 Q2 | 20.24 Million USD | -2.42% |
| 2014 FY | -619.41 Thousand USD | -103.23% |
| 2014 Q4 | -619.41 Thousand USD | -102.56% |
| 2014 Q3 | 24.2 Million USD | 19.6% |
| 2014 Q1 | 20.74 Million USD | 8.33% |
| 2013 FY | 19.14 Million USD | 134.05% |
| 2013 Q4 | 19.14 Million USD | 0.0% |
| 2012 FY | 8.18 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 99.845% |
| BrainsWay Ltd. | -10.32 Million USD | 100.407% |
| Cerus Corporation | 84.35 Million USD | 99.95% |
| Envoy Medical, Inc. | -3.81 Million USD | 101.101% |
| electroCore, Inc. | -9.95 Million USD | 100.422% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 100.82% |
| IceCure Medical Ltd | -9.93 Million USD | 100.423% |
| Inogen, Inc. | -103.56 Million USD | 100.041% |
| OrthoPediatrics Corp. | -9.26 Million USD | 100.453% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 101.154% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 100.321% |
| MaxCyte, Inc. | -27.76 Million USD | 100.151% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 100.817% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 107.295% |
| Orthofix Medical Inc. | 96.44 Million USD | 99.956% |
| PAVmed Inc | 29.08 Million USD | 99.856% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 100.248% |
| RxSight, Inc. | -6.68 Million USD | 100.629% |
| Sight Sciences, Inc. | -102.71 Million USD | 100.041% |
| SI-BONE, Inc. | 5.72 Million USD | 99.266% |
| TELA Bio, Inc. | -3.94 Million USD | 101.064% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 99.927% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 88.068% |
| Acutus Medical, Inc. | 12.27 Million USD | 99.658% |
| Talis Biomedical Corporation | -57.06 Million USD | 100.074% |
| Spectral AI, Inc. | -3.5 Million USD | 101.2% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 100.087% |
| CVRx, Inc. | -59.95 Million USD | 100.07% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 97.883% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 96.713% |
| Bioventus Inc. | 372.51 Million USD | 99.989% |
| Venus Concept Inc. | 74.3 Million USD | 99.943% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 100.412% |
| LivaNova PLC | 62.53 Million USD | 99.933% |
| 908 Devices Inc. | -115.09 Million USD | 100.036% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 99.987% |
| Nemaura Medical Inc. | 9.92 Million USD | 99.577% |
| NeuroPace, Inc. | 54.33 Million USD | 99.923% |
| LENSAR, Inc. | -18.31 Million USD | 100.229% |
| Apyx Medical Corporation | -5.15 Million USD | 100.815% |
| Cutera, Inc. | 288.3 Million USD | 99.985% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 99.441% |
| BioSig Technologies, Inc. | 262 Thousand USD | 83.969% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 100.096% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 100.457% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 99.997% |
| Axonics, Inc. | -77.19 Million USD | 100.054% |
| Outset Medical, Inc. | 67.67 Million USD | 99.938% |
| IRIDEX Corporation | -4.28 Million USD | 100.979% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 100.024% |
| IRadimed Corporation | -47.71 Million USD | 100.088% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 101.388% |
| INVO Bioscience, Inc. | 8.45 Million USD | 99.503% |
| Telesis Bio, Inc. | 32.63 Million USD | 99.871% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 101.679% |
| Varex Imaging Corporation | 316.9 Million USD | 99.987% |
| Quipt Home Medical Corp. | 81.73 Million USD | 99.949% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 101.51% |
| Pulmonx Corporation | -42.36 Million USD | 100.099% |
| Dynatronics Corporation | 6.2 Million USD | 99.323% |
| Modular Medical, Inc. | -8.04 Million USD | 100.522% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 100.977% |
| Semler Scientific, Inc. | -57.13 Million USD | 100.074% |
| InMode Ltd. | -135.39 Million USD | 100.031% |
| Bruker Corporation | 891.3 Million USD | 99.995% |
| Cytosorbents Corporation | 4.18 Million USD | 98.996% |
| DexCom, Inc. | 2.02 Billion USD | 99.998% |
| Align Technology, Inc. | -840.47 Million USD | 100.005% |
| Viveve Medical, Inc. | -13.81 Million USD | 100.304% |
| ZimVie Inc. | 450.41 Million USD | 99.991% |
| Movano Inc. | -5.86 Million USD | 100.716% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 100.031% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 107.295% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 97.883% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 99.988% |
| Profound Medical Corp. | -18.17 Million USD | 100.231% |
| Insulet Corporation | 798.1 Million USD | 99.995% |
| enVVeno Medical Corporation | -2.21 Million USD | 101.894% |
| Surmodics, Inc. | -12.01 Million USD | 100.35% |
| iCAD, Inc. | -21.2 Million USD | 100.198% |
| Nuwellis, Inc. | -2.81 Million USD | 101.49% |
| Biotricity, Inc. | 23.09 Million USD | 99.818% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 99.955% |
| Aethlon Medical, Inc. | -4.5 Million USD | 100.933% |
| InspireMD, Inc. | -8.04 Million USD | 100.522% |
| PAVmed Inc. | 29.08 Million USD | 99.856% |
| BIOLASE, Inc. | 11.34 Million USD | 99.63% |
| Beyond Air, Inc. | 6.22 Million USD | 99.326% |
| FONAR Corporation | -14.66 Million USD | 100.286% |
| AxoGen, Inc. | 32.26 Million USD | 99.87% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 100.394% |
| Inari Medical, Inc. | -7.16 Million USD | 100.587% |
| UFP Technologies, Inc. | 40.77 Million USD | 99.897% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 98.631% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 100.88% |
| Tenon Medical, Inc. | -1.25 Million USD | 103.347% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 100.552% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 100.352% |
| AdaptHealth Corp. | 2.21 Billion USD | 99.998% |
| Sintx Technologies, Inc. | 905 Thousand USD | 95.359% |
| NanoVibronix, Inc. | -3.27 Million USD | 101.281% |
| Quanterix Corporation | -132.95 Million USD | 100.032% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 101.51% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 100.188% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 99.994% |
| TransMedics Group, Inc. | 121.13 Million USD | 99.965% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 100.16% |
| NeuroMetrix, Inc. | -1.49 Million USD | 102.817% |
| Hyperfine, Inc. | -75.61 Million USD | 100.056% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 99.972% |
| Biomerica, Inc. | -3.38 Million USD | 101.241% |
| Bone Biologics Corporation | -3.02 Million USD | 101.388% |
| AVITA Medical, Inc. | -26.23 Million USD | 100.16% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 102.285% |
| Silk Road Medical, Inc | 64.42 Million USD | 99.935% |